Home/Filings/4/0001509284-25-000004
4//SEC Filing

Lipschultz Tyler 4

Accession 0001509284-25-000004

CIK 0001453593other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 5:06 PM ET

Size

5.6 KB

Accession

0001509284-25-000004

Insider Transaction Report

Form 4
Period: 2025-11-15
Transactions
  • Award

    Common Stock

    2025-11-15+158,228158,228 total
Footnotes (2)
  • [F1]These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes 158,228 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.

Issuer

Xtant Medical Holdings, Inc.

CIK 0001453593

Entity typeother

Related Parties

1
  • filerCIK 0001509284

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:06 PM ET
Size
5.6 KB